全文获取类型
收费全文 | 346篇 |
免费 | 22篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 7篇 |
妇产科学 | 9篇 |
基础医学 | 67篇 |
口腔科学 | 4篇 |
临床医学 | 43篇 |
内科学 | 54篇 |
皮肤病学 | 6篇 |
神经病学 | 12篇 |
特种医学 | 55篇 |
外科学 | 29篇 |
综合类 | 2篇 |
预防医学 | 40篇 |
眼科学 | 3篇 |
药学 | 11篇 |
中国医学 | 2篇 |
肿瘤学 | 23篇 |
出版年
2023年 | 4篇 |
2022年 | 1篇 |
2021年 | 7篇 |
2020年 | 5篇 |
2019年 | 8篇 |
2018年 | 7篇 |
2017年 | 8篇 |
2016年 | 5篇 |
2015年 | 7篇 |
2014年 | 14篇 |
2013年 | 18篇 |
2012年 | 30篇 |
2011年 | 46篇 |
2010年 | 14篇 |
2009年 | 12篇 |
2008年 | 23篇 |
2007年 | 31篇 |
2006年 | 22篇 |
2005年 | 30篇 |
2004年 | 22篇 |
2003年 | 17篇 |
2002年 | 9篇 |
2001年 | 1篇 |
2000年 | 1篇 |
1999年 | 3篇 |
1998年 | 6篇 |
1997年 | 4篇 |
1996年 | 1篇 |
1991年 | 2篇 |
1990年 | 1篇 |
1987年 | 1篇 |
1986年 | 1篇 |
1984年 | 1篇 |
1982年 | 1篇 |
1981年 | 1篇 |
1979年 | 3篇 |
1978年 | 1篇 |
排序方式: 共有368条查询结果,搜索用时 78 毫秒
41.
High dairy intakes have been associated with lower rates of obesity in observational studies, but mechanisms to explain the association are lacking. A high intake of dairy protein reduces spontaneous food intake and may be one important mechanism, but more specific effects of dairy calcium seem to exist.We have found that high versus low calcium intakes from dairy products had no effect on 24-h energy expenditure or substrate oxidation rates, but fecal fat excretion increased ∼ 2.5-fold on the high-calcium diets. In a meta-analysis of intervention studies we found that increasing dairy calcium intake by 1200 mg/day resulted in increased fecal fat excretion by 5.2 (1.6-8.8) g/day.Newer research shows that humans possess taste receptors for calcium in the gastrointestinal tract and that signaling may be linked to appetite regulation. A new line of evidence suggests that an inadequate calcium intake during an energy restricted weight loss program may trigger hunger and impair compliance to the diet.These mechanisms may be part of the explanation for the protective effects of dairy products with regard to obesity and metabolic syndrome. 相似文献
42.
43.
JA Chan KB Howell L Reiling R Ataide CL Mackintosh FJ Fowkes M Petter JM Chesson C Langer GM Warimwe MF Duffy SJ Rogerson PC Bull AF Cowman K Marsh JG Beeson 《The Journal of clinical investigation》2012,122(9):3227-3238
Plasmodium falciparum is the major cause of malaria globally and is transmitted by mosquitoes. During parasitic development, P. falciparum-infected erythrocytes (P. falciparum-IEs) express multiple polymorphic proteins known as variant surface antigens (VSAs), including the P. falciparum erythrocyte membrane protein 1 (PfEMP1). VSA-specific antibodies are associated with protection from symptomatic and severe malaria. However, the importance of the different VSA targets of immunity to malaria remains unclear, which has impeded an understanding of malaria immunity and vaccine development. In this study, we developed assays using transgenic P. falciparum with modified PfEMP1 expression to quantify serum antibodies to VSAs among individuals exposed to malaria. We found that the majority of the human antibody response to the IE targets PfEMP1. Furthermore, our longitudinal studies showed that individuals with PfEMP1-specific antibodies had a significantly reduced risk of developing symptomatic malaria, whereas antibodies to other surface antigens were not associated with protective immunity. Using assays that measure antibody-mediated phagocytosis of IEs, an important mechanism in parasite clearance, we identified PfEMP1 as the major target of these functional antibodies. Taken together, these data demonstrate that PfEMP1 is a key target of humoral immunity. These findings advance our understanding of the targets and mediators of human immunity to malaria and have major implications for malaria vaccine development. 相似文献
44.
Ustun C Slaby J Shanley RM Vydra J Smith AR Wagner JE Weisdorf DJ Young JA 《Biology of blood and marrow transplantation》2012,18(10):1580-1588
Human parainfluenza viruses (HPIVs) are uncommon, yet high-risk pathogens after hematopoietic stem cell transplant (HCT). We evaluated 5178 pediatric and adult patients undergoing HCT between 1974 and 2010 to determine the incidence, risk factors, response to treatment, and outcome of HPIV infection as well as any change in frequency or character of HPIV infection over time. HPIV was identified in 173 patients (3.3%); type 3 was most common (66%). HPIV involved upper respiratory tract infection (URTI; 57%), lower respiratory tract infection (LRTI; 9%), and both areas of the respiratory tract (34%), at a median of 62 days after transplantation. In more recent years, HPIV has occurred later after HCT, whereas the proportion with nosocomial infection and mortality decreased. Over the last decade, HPIV was more common in older patients and in those receiving reduced intensity conditioning (RIC). RIC was a significant risk factor for later (beyond day +30). HPIV infections, and this association was strongest in patients with URTI. HCT using a matched unrelated donor (MURD), mismatched related donor (MMRD), age 10 to 19 years, and graft-versus-host disease (GVHD) were all risk factors for HPIV infections. LRTI, early (<30 days), age 10 to 19 years, MMRD, steroid use, and coinfection with other pathogens were risk factors for mortality. The survival of patients with LRTI, especially very early infections, was poor regardless of ribavirin treatment. HPIV incidence remains low, but may have delayed onset associated with RIC regimens and improving survival. Effective prophylaxis and treatment for HPIV are needed. 相似文献
45.
46.
47.
48.
Maarten Kruijver Jo-Anne Bright Hannah Kelly 《The Australian journal of forensic sciences》2019,51(4):S14-S17
ABSTRACTIf an unambiguous single-source DNA profile is obtained from a crime scene, then a potential person of interest can either match or not match the crime scene profile and the likelihood ratio for the single matching genotype can be easily computed. Mixed DNA profiles on the other hand are typically ambiguous and a vast number of different likelihood ratios can be obtained depending on the genotype of a potential person of interest that is compared with the mixture later. In the absence of a person of interest it can be unclear how suitable the profile is for discriminating between donors and non-donors. We introduce a simulation method to explore the range of likelihood ratios that is expected to be obtained when a non-donor or a true donor is compared with the mixed DNA profile. Sampling is conditional on the mixture deconvolution obtained using probabilistic genotyping. These simulations help to decide whether or not a (mixed) profile is suitable for comparison to a person of interest. Moreover, the methods can be used to determine whether a profile is suitable for upload to a database and whether or not potential rework could be advised. 相似文献
49.
Luiz Guilherme Darrigo Junior Gisele Loth Cilmara Kuwahara Ana Vieira Vergilio Colturato Ana Luiza Rodrigues Leonardo Arcuri Juliana Fernandes Antonio Macedo Rita Tavares Alessandra Gomes Lisandro Ribeiro Adriana Seber Victor Zecchin Mair de Souza Rodolfo Calixto Ricardo Pasquini Mary Flowers Vanderson Rocha Carmem Bonfim 《European journal of haematology》2020,105(4):426-433
50.